Real-world treatment trends and triple class exposed status in newly diagnosed multiple myeloma patients in Japan: A retrospective claims database study

• Toyoki Moribe ,

  Contributed equally to this work with: Toyoki Moribe, Linghua Xu

  Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Writing – original draft, Writing – review & editing

  * E-mail: tmoribe1025@gmail.com

  Affiliation Oncology Medical Affairs, Pfizer Japan Inc., Tokyo, Japan

  https://orcid.org/0000-0002-7035-8791

  ⨯
• Linghua Xu ,

  Contributed equally to this work with: Toyoki Moribe, Linghua Xu

  Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing – review & editing

  Affiliation Access & Value, Pfizer Japan Inc., Tokyo, Japan

  ⨯
• Kazumi Take,

  Roles Formal analysis, Methodology, Writing – review & editing

  Affiliation Oncology Medical Affairs, Pfizer Japan Inc., Tokyo, Japan

  ⨯
• Naohiro Yonemoto,

  Roles Formal analysis, Methodology, Writing – review & editing

  Affiliation Access & Value, Pfizer Japan Inc., Tokyo, Japan

  ⨯
• Kenshi Suzuki

  Roles Conceptualization, Methodology, Writing – review & editing

  Affiliation Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan

  ⨯